Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring of tyrosine kinase inhibitors
NL-OMON53128Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of imatinib in cancer, sponsored by Netherlands Cancer Institute. Primary endpoint: Pharmacokinetics. Started Jun 2009; status: recruiting.
02
Drugs
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON53128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53128.